STMN1 and cancer: Taking into account the chalcones’ capability to act on multiple molecules, we hypothesized that CITs might not only target stathmin but also other microtubule-associated proteins that are deregulated in cancer cells, such as collapsin response mediator protein-2 (CRMP2, also known as DPYSL2).